A look back at the Antimicrobial Resistance Symposium – Bacteria, Fungi, Parasites and their Vectors

On November 29 and 30, the Institut Pasteur and the University of Paris organized their first joint symposium on antimicrobial resistance, a meeting with a specific focus on pathogenic bacteria, fungi, parasites and their vectors. This meeting was an opportunity for the two institutions to get to know each other better and to strengthen pre-existing interactions. It was also an opportunity to exchange information on their own and mutual research and teaching strategies on the fight of antimicrobial resistance. The aim was to network, foster interactions and the emergence of future collaborations.

In the frame of the recent association between the Institut Pasteur and the University of Paris, the symposium aimed at promoting the combination of the expertise of the different AMR laboratories to accelerate the understanding of resistance mechanisms and the development of innovative solutions to counter this major public health problem.

Christine Clerici, President of the University of Paris, and Stewart Cole, Director General of the Institut Pasteur, were particularly committed to the establishment of this new association and opened the symposium in the grand amphithéâtre rue de l’École de Médecine. Over the two days, there were 66 short presentations, interspersed with moments of conviviality to promote discussions and future collaborations for joint projects.

Hundred participants, research directors, researchers, MCU, PU-PH, engineers, technicians, post-doctoral fellows, doctoral students and students, were present from both institutions, with an homogenous distribution among the two.

During these two days, scientists and clinicians from the Institut Pasteur and the University of Paris were able to discuss the major advances in the AMR field in terms of clinical research, epidemiology, evolution and modeling, therapies targeting host-pathogen interactions, resistance, persistence, tolerance and dormancy, as well as new targets and new molecules to fight AMR.

Acces the program

For any information: emilie.boutet@pasteur.fr

Photos credits: Institut Pasteur, François Gardy - University of Paris, Eric Descarpentri